Perspectives on Treatment of Metastatic Castration-Resistant Prostate Cancer

被引：29
作者：
Merseburger, Axel S. [1 ]
Bellmunt, Joaquim [2 ]
Jenkins, Cheryl [3 ]
Parker, Chris [4 ]
Fitzpatrick, John M. [5 ,6 ]
机构：
[1] Hannover Med Sch, Dept Urol & Urol Oncol, D-30625 Hannover, Germany
[2] Univ Hosp Mar, Inst Invest Med, Med Oncol Serv, Barcelona, Spain
[3] Rocket Sci Med Commun, Wantage, Oxon, England
[4] Royal Marsden Natl Hlth Serv Fdn Trust, Sutton, Surrey, England
[5] Mater Misericordiae Hosp Univ Coll, Dept Surg, Dublin, Ireland
[6] Irish Canc Soc, Dublin, Ireland
来源：
ONCOLOGIST | 2013年 / 18卷 / 05期
关键词：
Metastatic castration-resistant; Prostate cancer; Treatment; Docetaxel; Cabazitaxel; Abiraterone acetate; Enzalutamide; CIRCULATING TUMOR-CELLS; ANDROGEN RECEPTOR GENE; MITOXANTRONE PLUS PREDNISONE; PHASE-II TRIAL; CLINICAL-TRIALS; BONE METASTASES; SIPULEUCEL-T; SKELETAL COMPLICATIONS; ABIRATERONE ACETATE; INCREASED SURVIVAL;
D O I：
10.1634/theoncologist.2012-0478
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The arrival of several new agents-cabazitaxel, abiraterone acetate, enzalutamide, and radium-223-is changing the treatment options and management of patients with metastatic castration-resistant prostate cancer (mCRPC). Many other novel agents are also being investigated. As new drugs become approved, new treatment strategies and markers to best select which patients will best respond to which drug are needed. This review article is a summary of a European Treatment Practices Meeting, which was convened to discuss these latest data on novel agents and current treatment strategies in the mCRPC setting.
引用
收藏
页码：558 / 567
页数：10
相关论文
共 115 条
  • [1] Bone-modifying agents in the treatment of bone metastases in patients with advanced genitourinary malignancies: a focus on zoledronic acid
    Aapro, Matti
    Saad, Fred
    [J]. THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (02) : 85 - 101
  • [2] The Mechanism of Action of Estrogen in Castration-Resistant Prostate Cancer: Clues From Hormone Levels
    Aggarwal, Rahul
    Weinberg, Vivian
    Small, Eric J.
    Oh, William
    Rushakoff, Robert
    Ryan, Charles J.
    [J]. CLINICAL GENITOURINARY CANCER, 2009, 7 (03) : E71 - E76
  • [3] [Anonymous], CLIN TEAM LEAD REV M
  • [4] [Anonymous], J CLIN ONCOL
  • [5] [Anonymous], J CLIN ONCOL
  • [6] [Anonymous], EUROPEAN ASS UROLOGY
  • [7] [Anonymous], ANN ONCOL
  • [8] [Anonymous], J CLIN ONCOL
  • [9] [Anonymous], PROSTATE CANC PROSTA
  • [10] A contemporary prognostic nomogram for men with hormone-refractory metastatic prostate cancer: A TAX327 study analysis
    Armstrong, Andrew J.
    Garrett-Mayer, Elizabeth S.
    Yang, Yi-Chun Ou
    de Wit, Ronald
    Tannock, Ian F.
    Eisenberger, Mario
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (21) : 6396 - 6403
12345678910